ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
84 319,97
0,43%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Silverback Therapeutics Inc (SBTX) Cours

Silverback Therapeutics Inc

Silverback Therapeutics Inc (SBTX)

Skinbiotherapeutics Plc
5,87
0,00
(0,00%)
Fermé 15 Mars 9:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
5,87
Prix Achat
2,37
Prix Vente
6,15
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
563,502M
Clôture Veille
5,87
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
95 997 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-20,96
Bénéfice par action (BPA)
-0,57
Chiffre d'affairess
30k
Bénéfice net
-54,37M

À propos de Silverback Therapeutics Inc

Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
ars-pharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-

SBTX Dernières nouvelles

Plus de nouvelles
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

SBTX - Frequently Asked Questions (FAQ)

What is the current Silverback Therapeutics share price?
The current share price of Silverback Therapeutics is US$ 5,87
How many Silverback Therapeutics shares are in issue?
Silverback Therapeutics has 95 997 000 shares in issue
What is the market cap of Silverback Therapeutics?
The market capitalisation of Silverback Therapeutics is USD 563,5M
What is the 1 year trading range for Silverback Therapeutics share price?
Silverback Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Silverback Therapeutics?
The price to earnings ratio of Silverback Therapeutics is -20,96
What is the cash to sales ratio of Silverback Therapeutics?
The cash to sales ratio of Silverback Therapeutics is 39,57k
What is the reporting currency for Silverback Therapeutics?
Silverback Therapeutics reports financial results in USD
What is the latest annual turnover for Silverback Therapeutics?
The latest annual turnover of Silverback Therapeutics is USD 30k
What is the latest annual profit for Silverback Therapeutics?
The latest annual profit of Silverback Therapeutics is USD -54,37M
What is the registered address of Silverback Therapeutics?
The registered address for Silverback Therapeutics is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
What is the Silverback Therapeutics website address?
The website address for Silverback Therapeutics is ars-pharma.com
Which industry sector does Silverback Therapeutics operate in?
Silverback Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
SBTX
Silverback Therapeutics
NASDAQ
FBWEX
Agf North American Divid...
ASX
IKE
ikeGPS
LSE
61PO
Sigma Fin.frn10
LSE
SK16
Saudi.arab 54 R
LSE
88DL
Sse 38
LSE
32AJ
Sigma Fin.frn14
LSE
94RO
Sse 1.750% 23
TSX
RQK
RBC Target 2023 Corporat...
TG
AGCA
Air Liquide Finance
LSE
69BP
Sg Issuer 23
TG
PV3B
EyePoint Pharmaceuticals
TG
D7KB
German Credit Bank
TG
BOK
Boozt AB
LSE
61DG
Smiths Grp27
LSE
16NP
Diageo Bv.28
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces